Company Information & Drug Savings for Akcea Therapeutics Medications
Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, is a biopharmaceutical company focused on developing and commercializing RNA-targeted therapies for lipid disorders. Based in Cambridge, Massachusetts, Akcea developed Tegsedi (inotersen) for hereditary transthyretin-mediated amyloidosis and treatments for familial chylomicronemia syndrome (FCS). The company specializes in antisense oligonucleotide technology for rare genetic diseases affecting lipid metabolism.
How to Contact Akcea Therapeutics
Phone
1-617-207-0202Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
